Free Trial

Alliance Pharma (APH) Insider Trading & Ownership

Alliance Pharma logo
GBX 45.30
+0.55 (+1.23%)
(As of 11/1/2024 ET)

Alliance Pharma (LON:APH) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.95%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
£45,053.05
Number Of
Insiders Selling
(Last 3 Years)
2
Amount Of
Insider Selling
(Last 3 Years)
£291,206.01
Get APH Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alliance Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

APH Insider Buying and Selling by Quarter

Alliance Pharma Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2023Andrew FranklinInsiderSell42,053GBX 39£16,400.67
7/20/2023Jo Le CouilliardInsiderBuy40,957GBX 49£20,068.93
7/18/2023Andrew FranklinInsiderBuy50,988GBX 49£24,984.12
11/19/2021Peter ButterfieldInsiderSell269,417GBX 102£274,805.34
(Data available from 1/1/2013 forward)

APH Insider Trading Activity - Frequently Asked Questions

The list of insiders at Alliance Pharma includes Andrew Franklin, Jo Le Couilliard, and Peter Butterfield. Learn more on insiders at APH.

11.95% of Alliance Pharma stock is owned by insiders. Learn more on APH's insider holdings.

The following insiders have purchased APH shares in the last 24 months: Andrew Franklin (£24,984.12), and Jo Le Couilliard (£20,068.93).

Insiders have purchased a total of 91,945 APH shares in the last 24 months for a total of £45,053.05 bought.

The following insider sold APH shares in the last 24 months: Andrew Franklin (£16,400.67).

Insiders have sold a total of 42,053 Alliance Pharma shares in the last 24 months for a total of £16,400.67 sold.

Alliance Pharma Key Executives

  • Mr. Andrew Timothy Franklin (Age 58)
    CFO & Executive Director
    Compensation: $271.52k
  • Mr. Peter Jonathan Butterfield (Age 48)
    Executive Officer
    Compensation: $399.83k
  • Mr. Nick Sedgwick
    Chief Executive Officer
  • Mr. Jeyan Heper (Hons) (Age 50)
    BA, COO & Director
  • Mr. Stephen Kidner
    Chief Scientific Affairs Officer
  • Ms. Cora Maeve McCallum C.F.A.
    Head of Investor Relations & Corporate Communications
  • Mr. Christodoulos Theoclis Chrysanthou
    Group General Counsel & Company Secretary
  • Mr. Alex Duggan
    Chief Commercial & Corporate Development Officer
  • Julie Skinner
    Chief People Officer
  • Chris Delafield
    Global Marketing Head of Kelo-Cote


This page (LON:APH) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners